학술논문
A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia
Document Type
Article
Author
Source
In Blood 1 December 1999 94(11):3694-3701
Subject
Language
ISSN
0006-4971